Home
About
Publications Trends
Recent Publications
Expert Search
Archive
gene ontology
What Tools and Databases Utilize Gene Ontology for Cancer Research?
Several tools and databases incorporate GO annotations to facilitate cancer research:
-
GSEA (Gene Set Enrichment Analysis)
: Helps identify enriched GO terms in gene expression datasets.
-
DAVID (Database for Annotation, Visualization, and Integrated Discovery)
: Provides functional annotation of large gene lists, including GO terms.
-
STRING (Search Tool for the Retrieval of Interacting Genes/Proteins)
: Integrates GO annotations to predict protein-protein interactions.
Frequently asked queries:
What is Gene Ontology?
How Does Gene Ontology Help in Cancer Research?
Which Gene Ontology Categories are Most Relevant to Cancer?
How Can Gene Ontology Be Applied to Identify Cancer Biomarkers?
What Tools and Databases Utilize Gene Ontology for Cancer Research?
Can Gene Ontology Aid in Understanding Drug Resistance in Cancer?
How Does Gene Ontology Assist in Personalized Cancer Therapy?
What Are the Challenges in Using Gene Ontology for Cancer Research?
How are These Reviews Conducted?
What are the Treatment Options for Lung Damage?
How Important is Time Management During Cancer Treatment?
What Role Do Molecular Profiles Play?
What is Prolaris?
How Can Technology Enhance QoL for Cancer Patients?
What is the Future of VEGF Pathway Research in Cancer?
What are the Statistics on Cancer Prevalence?
How Do Intestacy Laws Vary by Jurisdiction?
How Can an Attorney Help with Medical Malpractice Claims?
How is Cryptorchidism Linked to Cancer?
What are the Challenges and Limitations of BET Inhibitors?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe